Overview

Study of Fish Oil to Reduce ALT Levels in Adolescents

Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This trial will provide preliminary data to test the hypothesis that a six-month treatment period with fish oil for overweight adolescent with mild to moderate persistent elevation of ALT levels and presence of hepatic steatosis on CT-scan is safe and will result in decreased ALT.
Phase:
Phase 1
Details
Lead Sponsor:
Boston University
Collaborator:
GlaxoSmithKline